Epidemiological and molecular investigation of resurgent cutaneous leishmaniasis in Sudan. by Collis, Sarah et al.
LSHTM Research Online
Collis, Sarah; El-Safi, Sayda; Atia, Atia A; Bhattacharyya, Tapan; Hammad, Awad; Den Boer, Mar-
griet; Le, Hai; Whitworth, James A; Miles, Michael A; (2019) Epidemiological and molecular inves-
tigation of resurgent cutaneous leishmaniasis in Sudan. International journal of infectious diseases.
ISSN 1201-9712 DOI: https://doi.org/10.1016/j.ĳid.2019.08.018
Downloaded from: http://researchonline.lshtm.ac.uk/id/eprint/4654557/
DOI: https://doi.org/10.1016/j.ĳid.2019.08.018
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
Epidemiological and molecular investigation of resurgent
cutaneous leishmaniasis in Sudan
Sarah Collisa, Sayda El-Saﬁb, Atia A. Atiac,d, Tapan Bhattacharyyaa,*, Awad Hammadb,
Margriet Den Boere,f, Hai Lea, James A. Whitwortha, Michael A. Milesa
a London School of Hygiene and Tropical Medicine, London, UK
b Faculty of Medicine, University of Khartoum, Sudan
cWorld Health Organization, Sudan
dKalaCORE Consortium, Sudan
eMédecins Sans Frontières, Amsterdam, The Netherlands
fKalaCORE Consortium, London, UK
A R T I C L E I N F O
Article history:
Received 10 June 2019
Received in revised form 13 August 2019
Accepted 14 August 2019
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark
Keywords:
Sudan
Leishmania major
Cutaneous leishmaniasis
Epidemiology
A B S T R A C T
Objectives: Local health personnel have drawn attention to an apparent increase in incidence and severity
of cutaneous leishmaniasis (CL) in Sudan. The objective of this study was to investigate CL burden and
surveillance.
Methods: Surveillance data were compiled from the KalaCORE programme, Leishmania coordinators in
Northern Kordofan and Southern Darfur, and Khartoum Dermatology Hospital. CL lesions were sampled
from 14 suspected cases from Northern Kordofan and the Hospital for Tropical Diseases in Omdurman.
PCR–restriction fragment length polymorphism analysis and multilocus sequencing were used to
characterize the disease agent.
Results: All sites reported substantial increases from 2014 to 2016/7, far exceeding World Health
Organization case reports for 2014, consistent with a widespread outbreak. Single seasonal peak
incidence was observed, except for two peaks in Southern Darfur. In Northern Kordofan, the odds ratio for
CL in the 35–44 years age group was 2.6 times higher than in the >45 years age group (p < 0.0001); in
Southern Darfur, the OR was 2.38 greater in males than females (p < 0.0001). Lesions included severe
presentations, despite chemotherapy. Leishmania major was identiﬁed as the agent.
Conclusions: Active surveillance is required to understand the extent of CL in Sudan, as well as training to
standardize surveillance, diagnosis, reporting, and quality control. Point-of-care rapid diagnosis would
be valuable. Genotyping and phenotyping are required to monitor the emergence of pathogenic strains,
drug resistance, outbreaks, and changes in severity.
© 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction
Cutaneous leishmaniasis (CL) is the most common form of the
leishmaniases, which are caused by Leishmania protozoa. These are
transmitted by female phlebotomine sand ﬂies and principally
affect impoverished and weakened populations. CL is endemic in
98 countries, with an estimated 0.6 million to 1 million new cases
occurring annually (Alvar et al., 2012). The agents of CL in eastern
Africa are principally Leishmania tropica, Leishmania major, and
Leishmania aethiopica, with different clinical outcomes. In Sudan,
L. major, of the strain group named zymodeme LON-1, is considered
commonly responsible for CL; L. tropica is known from neighbour-
ing countries such as Egypt, Kenya, and Ethiopia (World Health
Organization, 2010). Life-threatening visceral leishmaniasis (VL) is
due to Leishmania donovani in eastern Africa and Leishmania
infantum along the Mediterranean coast.
CL can mimic many other skin conditions (World Health
Organization, 2018a). Parasitological conﬁrmation via microscopy
remains the gold standard of CL diagnosis and is the most
affordable approach, but relies heavily on parasite yield, sampling,
* Corresponding author at: Department of Infection Biology, Faculty of Infectious
and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel
Street, London, WC1E 7HT, UK.
E-mail addresses: sarah.collis@uk-med.org (S. Collis), shelsaﬁ@yahoo.com
(S. El-Saﬁ), atia.alatiaby@kalacore.org (A.A. Atia),
tapan.bhattacharyya@lshtm.ac.uk (T. Bhattacharyya), goloyan62@yahoo.com
(A. Hammad), margrietdenboer@gmail.com (M. Den Boer), le.hai@kcl.ac.uk (H. Le),
Jimmy.Whitworth@lshtm.ac.uk (J.A. Whitworth), Michael.Miles@lshtm.ac.uk
(M.A. Miles).
https://doi.org/10.1016/j.ijid.2019.08.018
1201-9712/© 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
International Journal of Infectious Diseases 88 (2019) 14–20
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
journal homepage: www.elsevier .com/ locate / i j id
quality of stained slides of skin biopsies, and the skills and
experience of personnel (Reithinger et al., 2007; World Health
Organization, 2014). Alternative molecular detection techniques
on either skin or blood might offer greater sensitivity, but these are
not widely available or standardized (de Vries et al., 2015; Vink
et al., 2018; World Health Organization, 2014).
Although rarely fatal, the disease can leave substantial scarring
and disﬁgurement, with stigmatization and social exclusion. In
Africa, chemotherapy with pentavalent antimonials, such as the
generic sodium stibogluconate (SSG) given intralesionally or
intravenously, is only indicated for lesions lasting more than 6
months, multiple or large lesions, or lesions on a joint or the face
(World Health Organization, 2010). Alternative treatments may be
local paromomycin and methylbenzethonium or oral ﬂuconazole
(Burza et al., 2018; World Health Organization, 2010). Treatment
costs and hospital visits can be a signiﬁcant ﬁnancial burden for
families and public health resources.
The World Health Organization (WHO) Leishmaniasis Coordina-
tor for Sudan recently reported an apparent increase in cases of CL
with an unusuallyaggressive manifestation, atypical for the endemic
L. major, and for which the disease agent had not been identiﬁed
(unpublished observations, current authors SE-S and AAA). Thus,
the purpose of this investigation was to review the epidemiological
surveillance data and to characterize the disease agent.
Methods
Epidemiological data
All CL cases in the datasets analysed here were reported to the
authors of this study as being parasitologically conﬁrmed.
Epidemiological data were supplied from the following sources:
1 The KalaCORE consortium (http://www.kalacore.org/), which
supports the control and elimination of VL in Africa and Asia.
KalaCORE concomitantly collected limited Sudanese CL inci-
dence data for 2016. Data were analysed in Microsoft Excel. Sex,
age, and treatment data were not available.
2 Khartoum Dermatology Hospital (KDH), a nationwide CL referral
centre. KDH provided the data for 2012–2016 that were analysed
here. It was unclear from which exact populations the cases
originated, thus odds ratios (OR) for geographical origin were
not calculated. Excel was used for analysis.
3 Theministriesofhealth(MOHs)ofNorthernKordofanandSouthern
Darfur states. The Northern Kordofan Health Information System
(HIS) reported the incidence of CL for 2010 to June 2016. The
Leishmania coordinator for Northern Kordofan provided line listing
ofparasite-conﬁrmedCLpatientswhoattendedthetwohospitalsat
El Obied and Um Ruwaba for July 2016 to July 2017, based on
monthly reporting by healthcare professionals. Southern Darfur
gave corresponding information for January 2016 to August 2017.
Line listings on consultation date, age, and sex were translated into
English, transferred to Excel, and the data cleaned manually. ORs for
age and sex were derived in Stata 14 using projected population
estimates for 2016 (Central Bureau of Statistics, Republic of Sudan).
Values of p < 0.05 were considered signiﬁcant.
Reports on surveillance, laboratory training, and treatment
challenges for Northern Kordofan and for the Hospital for Tropical
Diseases (HTD) in Omdurman, Khartoum, were consulted in
collaboration with community and hospital teams.
Clinical samples
All samples from lesions were collected by authorized local
technical staff. A total of 14 suspected CL patients with active
(not dry or healing) skin lesions were identiﬁed for analysis of
Leishmania spp, as described below. Samples CL01–CL08 were
collected in remote areas of Northern Kordofan. The remaining six
samples (CL10–CL15) were taken at the HTD clinic. Samples for
microscopic and PCR analysis were collected by pipette from slit
skin smears, with four samples taken from each patient: (1)
directly onto Whatman FTA card (WHAWB120210; Sigma-Aldrich,
UK); (2) into ATL buffer (939011; Qiagen, UK); (3) into sterile
vacuettes (454001; Greiner, UK) containing 2 ml of RPMI culture
medium (R0883; Sigma), supplemented with 10% foetal calf serum
(F9665; Sigma), penicillin–streptomycin (P4333; Sigma), and
5-ﬂuorocytosine (F7129; Sigma); and (4) as a smear on slides,
taken previously and examined by local personnel before this
study for the presence of amastigotes.
DNA extraction
DNA extraction From ATL buffer samples and cultures was
performed using the QIAamp DNA Mini Kit (51304; Qiagen)
according to the manufacturer’s instructions.
Leishmania species identiﬁcation and multilocus sequence typing
(MLST)
ITS1-HaeIII PCR–restriction fragment length polymorphism
(PCR-RFLP) analysis was applied for species identiﬁcation (Schönian
et al., 2003); MLST was performed on genes previously established
for Leishmania typing, encoding cytosolic NADP-malic enzyme
(ME), fumarate hydratase (FH), and 6-phosphogluconate dehydro-
genase (PGD) (Supplementary material, Table S1) (Zemanova et al.,
2007). Puriﬁed MLST amplicons were sequenced bi-directionally
and compared with genome sequences for L. major strains, accessed
via www.TriTrypdb.org: Friedlin (MHOM/IL/81/Friedlin) (Ivens
et al., 2005), LV39 (MRHO/SU/59/P) (Rogers et al., 2011), and
SD75 (MHOM/SN/74/SD) (National Center for Biotechnology
Information, 2012). These three strains originate from Israel,
Uzbekistan, and Senegal, respectively.
Results
Epidemiological observations
Geographical sources of CL epidemiological data and clinical
samples are shown in Figure 1A. KalaCORE nationwide CL case
incidence data per month and by state in 2016, reported to the
WHO Leishmania coordinator from each state’s MOH department,
indicated a total of 804 new CL cases from Northern Darfur,
Southern Darfur, Northern Kordofan, Southern Kordofan, El Gezira,
and Khartoum states. The highest numbers of new cases were in
the winter months (January, February, November, December) and
the lowest in the summer months (Figure 1B). Separate analysis by
state showed that Southern Darfur reported additional peaks in
May and October (Figure 1C).
KDH reported a total of 3801 CL cases between 2012 and 2016
(Table 1). Compared to cases in 2013 (n = 416), the number of cases
increased more than threefold in both 2014 (n = 1350) and 2015
(n = 1421), indicating an outbreak starting in 2014. The 1350 cases
seen at KDH alone in 2014 was more than the 1053 cases that the
WHO reported in the same year for the entire country (World
Health Organization, 2018b). Overall, between 2012 and 2016 there
were consistently more cases among males than females,
cumulatively 2178 (57.3%) male cases compared to 1599 female
cases; sex was not recorded for 24 cases (Table 1). Most cases were
in the 15–24 years age group (n = 1080, 28.4%), followed by the
25–44 years age group (n = 974, 25.6%); the fewest cases were in
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infants less than 1 year of age (n = 72, 1.9%), followed by those older
than 60 years (n = 136, 3.6%) (Table 1).
Between January 2016 and August 2017, Southern Darfur MOH
reported a total of 342 CL cases: 159 in 2016 and 180 in 2017; the
year was not speciﬁed for three cases. The seasonal trend for 2017
cases was the opposite of that for 2016 cases (Figure 2A). In
Northern Kordofan, MOH-HIS reported 102 cases between 2010
and June 2016, of which ﬁve were reported before 2015. Two
hundred and ﬁfteen CL cases were reported from the two hospital
line listings between July 2016 and July 2017. In the ﬁrst 6 months
of 2017 alone, cases were more than double those in each of the
previous 2 years reported by MOH-HIS (Figure 2B). The highest
number of cases was reported in February 2017 (Figure 2C).
Data reported from Southern Darfur and Northern Kordofan
MOHs included the age and sex distribution of CL cases, from
which ORs were calculated. In Southern Darfur, age was reported
for 335 of 342 cases. Of all cases, 50% were in the 11–18 years and
19–30 years age groups (Figure 2D), with the fewest cases in those
>45 years of age. There was no signiﬁcant difference in ORs
between age groups. Of the 342 cases, 247 (72.2%) were male, and
the OR of CL in the males was over twice that in the females
(OR 2.38, 95% conﬁdence interval (CI) 1.87–3.05, p < 0.0001)
(Supplementary material, Table S2).
In Northern Kordofan, the majority of cases were in age groups
19–30 years (27.4%) and 31–45 years (25.6%), and the fewest in
those >45 years of age (5.1%) (Figure 2D). The age group 35–44
Table 1
Cutaneous leishmaniasis cases reported by Khartoum Dermatology Hospital 2010–2016.
2012 2013 2014 2015 2016 Total
All cases Number 206 416 1350 1421 408 3801 (100%)
Sex Male 112 249 775 809 233 2178 (57.3%)
Female 94 167 575 612 151 1599 (42.1%)
Not recorded – – – – 24 24 (0.6%)
Age (years) <1 7 8 25 26 6 72 (1.9%)
1–4 37 33 118 126 30 344 (9.1%)
5–14 41 88 341 341 96 907 (23.9%)
15–24 48 146 367 391 128 1080 (28.4%)
25–44 55 96 337 358 128 974 (25.6%)
45–59 10 32 107 128 11 288 (7.6%)
60+ 8 13 55 51 9 136 (3.6%)
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Figure 1. KalaCORE data. (A) Geographical sources of data. (B) KalaCORE cutaneous leishmaniasis data for 2016 (blue bars), with temperature and rainfall data for 2015
overlaid, indicating a decrease in case reports with rising rainfall. (C) KalaCORE individual state data showing that Southern Darfur had additional peaks of case reports in May
and October.
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years had 2.6 times the OR of CL when compared to those >45 years
of age (p = 0.0004); in the 20–34 years group this was 2.1 times
(p = 0.0030), but with no signiﬁcant difference when compared to
the 0–19 years age group (p = 0.6525) (Supplementary material,
Table S2). Of the 215 cases, 108 (50.2%) were male and 105 (48.8%)
were female (sex not reported in two cases), with an OR of CL in the
male subjects slightly higher than that in female subjects (OR 1.11,
95% CI 0.84–1.47), but this was not statistically signiﬁcant
(p = 0.45) (Supplementary material, Table S2).
Clinical presentation
Of the 14 lesion samples collected, coded here as CL01–CL08
and CL10–CL15, four were from females and 10 were from males.
The average age of individuals from whom lesions were sampled
was 22 years (range 3–67 years). Four participants lived in huts
made from tree branches, four in a mosque, two outside, three in a
house, and one in a tent. Only one participant reported using a
bed net. Two participants were classiﬁed as refugees. Ten
participants reported the onset of symptoms between 7 days
and 4 months previously. Four had chronic lesions (CL10, CL11,
CL12, CL14), with onset of symptoms ranging from 1 to 4 years. All
suspect lesions were located on limbs, except for patient CL10
who had nodular lesions on the nose and ear. The lesions ranged
in size from 2.5 cm to 10 cm in diameter. Seven lesions were
ulcerative, three nodular-ulcerative, and four nodular. At least
three out of 14 participants (CL10, CL11, CL12) had received SSG
treatment prior to sampling. Examples of lesions are shown in
Figure 3A–E.
Samples CL01–CL08 were collected in remote areas of
Northern Kordofan. Samples CL05 and CL06 originated from
the same village near Barrah. The samples belonged to a
3-year-old female and 4-year-old male, respectively. Both lived
in straw huts in a farming community and appeared visibly
malnourished. CL05 had a single lesion that was ulcerative,
painless, and approximately 3 cm in diameter, with symptoms
beginning approximately 4 months earlier. CL06 had two
ulcerative lesions that were painless and approximately 3 cm
in diameter, with symptoms of the ﬁrst lesion beginning
approximately 2 months earlier. CL08, a 55-year-old male
soldier who normally lived outside or in a tent in Northern and
Southern Kordofan, had six nodular-ulcerative lesions,
approximately 4 cm in diameter, situated on both his arms
and legs. Symptoms began 2 months prior to sampling. The
remaining six samples (CL10–CL15) were collected at the HTD
clinic, where severe lesions were also seen that were 2 to 3
years old (CL11, CL12), previously parasitologically conﬁrmed,
and non-responsive to SSG treatment (Figure 3). At HTD, where
CL lesions had been seen in patients with co-infections, an
18-year-old male from Eastern Sudan was admitted with both
VL and active CL lesions on the hand and elbow, with urinary
tract, malaria, and HIV co-infections.
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Figure 2. Southern Darfur and Northern Kordofan Ministry of Health data. (A) Southern Darfur Ministry of Health cutaneous leishmaniasis case reports showing differing
proﬁles in 2016 (blue line) and 2017 (orange line). (B) Northern Kordofan cutaneous leishmaniasis cases reports by the Ministry of Health – Health Information System
between 2010 and June 2016 (blue bars), and by hospital line listing from July 2016 to July 2017 (red bars), showing a sharp increase from 2015. (C) Northern Kordofan State
cutaneous leishmaniasis case reports between July 2016 and July 2017, for which the month was reported, showing a peak in winter (February); 46 cases were excluded as the
month was not reported. (D) Age distribution of cases, Southern Darfur (blue bars) and Northern Kordofan (orange bars).
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Leishmania species identiﬁcation and characterization
DNA from FTA cards could not be successfully ampliﬁed. For
extractions from ATL buffer, PCR-RFLP results were obtained for
samples CL05 and CL06, which both had fragment sizes
characteristic of L. major (203 bp and 132 bp, in accordance
with the species-speciﬁc pattern described by Schonian et al.)
(Schönian et al., 2003) (Figure 4A). From the inoculated cultures,
Leishmania from CL08 (hereafter named as isolate MHOM/SD/
2017/ELOBIED) generated abundant motile promastigotes from
which DNA was extracted and used for PCR-RFLP, also yielding the
fragment sizes of L. major (Figure 4B). MLST of MHOM/SD/2017/
ELOBIED produced the expected amplicon sizes (ME, 1653 bp; FH,
1707 bp; PGD, 1440 bp), and DNA sequencing veriﬁed L. major.
Comparison of these sequences with the reference L. major
genomes revealed 99–100% identity (Supplementary material,
Table S3). Nucleotide sequences derived here are available in
GenBank under accession numbers MK650465, MK650466, and
MK650467. MLST targets were not successfully ampliﬁed from
CL05 and CL06 DNA extracted from ATL buffer.
Discussion
Epidemiology and surveillance
CL principally occurs in populations burdened by poverty,
associated with exposure to vectors, poor housing, and population
displacement, with a weak immune system, and a lack of economic
and health resources (Reithinger et al., 2007; World Health
Organization, 2010). Males and females differ in susceptibility to
some infectious diseases in an age-dependent manner. A study in
Brazil showed a higher incidence of CL caused by New World
Leishmania spp in males than females, with this disparity
increasing with age (Guerra-Silveira and Abad-Franch, 2013).
However, for CL it appears that they may be affected equally if both
sexes participate in activities/behaviours with high exposure to
sand ﬂies (Karimkhani et al., 2016). The presence of infection may
depend on immune competence limited by age, impaired by
malnutrition or co-infection with HIV, or due to a lack of herd
immunity as naïve susceptible individuals accumulate and as
populations migrate (World Health Organization, 2010). For
L. major the incubation period can be less than 4 months, with
lesions that may ulcerate and heal within 2–8 months; however,
there may be multiple lesions and secondary infections.
Epidemics of CL in Sudan were reported in 1976 in Shendi-
Atbara, north of Khartoum (Abdalla and Sherif, 1978), and in 1986
in Khartoum State (el-Saﬁ and Peters, 1991; el-Saﬁ et al., 1991).
L. major zymodeme LON-1 was identiﬁed from the latter epidemic,
with a case of diffuse cutaneous leishmaniasis (DCL) reported to be
due to this species (Abdel-Hameed et al., 1990). There have been
descriptions of uncommon presentations associated with L. major
(Elamin et al., 2005), and of isolates from cutaneous lesions
identiﬁed as L. donovani (Elamin et al., 2008). Zymodeme MON-74
has also been reported in Sudan (Pratlong et al., 2009), as has
L. major/HIV co-infection (Mukhtar et al., 2010).
The WHO deﬁnes an epidemic threshold as an increase during a
similar period that at least doubles compared to 5–10 years of
previous data. As described here, from the KDH data, Sudan as a
whole has been experiencing increased cases of CL since 2014, and
Northern Kordofan has also experienced large increases from 2015,
which fulﬁl the WHO criteria. However, this increase might be due
in part to additional reporting and increased awareness. As CL has
never been a mandatory notiﬁable disease in Sudan, MOH data
before 2014 are not generally available.
Seasonality, as expected from ﬂuctuating sand ﬂy abundance,
was apparent from the occurrence of more CL cases in months with
lower temperatures and rainfall, except for Southern Darfur
(Figure 1B, C). The wider spread of peaks in Southern Darfur
may be due to fewer months of rainfall, variation in reporting
patterns, or the presence of conﬂict in Southern Darfur, which may
inﬂuence when patients can access health care, or changes in
reporting patterns.
In the 1986 CL epidemic in Khartoum State, individuals were
affected irrespective of sex, age, ethnic origin, or socio-economic
status, suggesting a lack of immunity in the population (el-Saﬁ and
Peters, 1991). According to the Northern Kordofan and Southern
Darfur MOH data analysed here, fewer cases occurred in those
<10 years and >45 years of age compared to the majority of cases
between 15 and 44 years old. In Northern Kordofan, these age-
related ORs were highly signiﬁcant, suggesting the following:
increased vector exposure among adult agriculturalists, as
observed in Ethiopia (Lemma et al., 2015), some protection of
Figure 3. Cutaneous leishmaniasis lesions. (A)–(C) Northern Kordofan State: (A)
CL05, (B) CL06, (C) CL08. (D) and (E) Hospital for Tropical Diseases, Omdurman: (D)
CL11, 3-year-old lesion, reported as Pentostam-resistant with multiple secondary
infections, (E) CL12, a 2-year-old cutaneous lesion on the ankle of a sickle cell
anaemia patient, also not responding to treatment. (F) Straw huts in a remote
farming village near Barrah, North Kordofan State. Leishmania major was identiﬁed
in samples from this location (CL05 and CL06).`
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infants against exposure, and more common life-long immunity
among adults >45 years old. The sex distribution was also skewed
in Southern Darfur, with the OR for males more than twice that for
females, indicative of a difference in behavioural exposure.
However, Southern Darfur State is one of the most populous,
including refugees and displaced persons (UNHCR, 2019), and
there is likely to be a higher proportion of male soldiers present
compared to other regions. Cases in females may also be under-
reported if they are less likely to access healthcare facilities.
Several limitations applied to our analyses. In Northern
Kordofan and Southern Darfur, there was limited data collection
on clinical presentation, treatment, and symptom onset, and no
recording of potential risk factors such as immunological status,
socio-economic status, and occupation. Due to self-healing of
many lesions, as well as poverty and poor access to treatment,
many CL patients do not attend healthcare facilities. There were
also some inconsistencies between data sources, as in the
comparison between 2014 data reported by the WHO (1053 cases
for the whole country) and by KDH (1350 cases in this clinic alone).
Furthermore, sampling was not focused on seasonal peak.
Thus, it is still difﬁcult to ascertain the true extent of the burden
of CL in Sudan, as recognized for African foci generally (Alvar et al.,
2012; Sunyoto et al., 2018), and there is an important need for
further systematic surveillance and monitoring of CL prevalence
and incidence.
Disease severity and Leishmania genetic diversity
Prior to this study, leishmaniasis coordinators in Sudan
(including current authors SE-S and AAA) reported both an
epidemic increase in cases and more aggressive pathology, unusual
for seasonal CL. As L. major typically causes more benign self-
healing ulcers (World Health Organization, 2010), it was postulat-
ed that there was a different disease agent, possibly L. tropica,
L. aethiopica, a novel emergent species, or a new strain of L. major.
Here, in the context of a recent CL outbreak in Sudan, PCR-RFLP
was used to identify L. major in three lesions from three out of 14
patients. Two individuals were young children at the same school.
The third was an adult male, from whom MHOM/SD/2017/ELOBIED
was isolated; MLST of this isolate revealed >99% sequence identity
with reference L. major genomic targets (Supplementary material,
Table S3).
It was surprising that L. major was detected in only three of the
14 individuals with suspected CL. Although CL10, CL11, and CL12
had been diagnosed at other Sudanese health care facilities by
microscopy and CL11 via PCR, it was not known whether the
lesions had been treated, and two of the four chronic lesions
(CL11 and CL12) had secondary bacterial infections. Lesion
sampling and storage may have been suboptimal; PCR with FTA
card samples has unproven sensitivity. Even for well-trained,
skilled technologists, diagnosis by microscopy is demanding. In El
Obied Hospital, Northern Kordofan and the HTD in Omdurman,
experience in CL lesion sampling diagnoses is limited, and there is a
lack of quality control. Thus, false-positive and false-negative
results are possible; diagnosis is often made clinically due to a lack
of diagnostic resources, and other dermatological conditions may
mimic CL.
Other thanparasite factors, possible explanations forthe reported
increase in CL severity include severe malnutrition, increased HIV
co-infections, or a population with a more vulnerable genetic
background. The current famine declared in South Sudan has
brought around a million refugees (UNHCR, 2019). Such population
movement is likely to bring an inﬂux of susceptible individuals. In
2014, the spatial sampling survey revealed that 52 of the 184
localities in Sudan had a severe acute malnutrition rating (SAM) of
‘very critical’ (>3%); Southern Darfur was one of three states with the
highest SAM recording of >20% (UNICEF, 2014).
Conclusions and recommendations
Although cases have indeed increased, and we have conﬁrmed
that L. major is associated with active outbreaks, further
surveillance is necessary to uncover the true extent of CL in
Sudan. Ideally, simple and standardized surveillance tools could be
implemented that promote the systematic recording of essential
epidemiological information, such as age, sex, date of symptom
onset, and geographical location. Workshops to train relevant
personnel could be provided, especially for state MOH Leishmania
coordinators, to undertake such basic epidemiological surveys in
future studies. Aided by remote communication, perhaps obliga-
tory reporting of these data to designated hubs run jointly by the
MOH and the WHO could occur on a regular basis (e.g., monthly).
Similarly, high quality training of laboratory technicians in
sampling techniques and the diagnosis of Leishmania infection by
microscopy could be implemented through workshops. Quality
control procedures between state MOH laboratories and specialist
Leishmania centres might be feasible to ensure the reliability of the
results. Failure to establish quality control may result in further
ambiguity of HIS data and line listings that are reported as
parasitologically conﬁrmed.
Figure 4. PCR-RFLP identiﬁcation of Leishmania species from cutaneous leishmaniasis lesions. (A) DNA extracted from ATL buffer, CL05 and CL06 produced the RFLP pattern
characteristic of Leishmania major, with band sizes as described in the text. (B) DNA extracted from culture of the isolate from CL08 (MHOM/SD/2017/ELOBIED) also gave the
pattern typical of L. major; PCR-RFLP of L. tropica was included as control. The L. major identiﬁcation was veriﬁed by DNA sequencing (see text).
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In future research, the development of a reliable point-of-care
(POC) rapid diagnostic test (RDT) fulﬁlling ASSURED criteria
(Peeling et al., 2006) would be of great value. Wider phenotypic
studies of drug susceptibilities in vitro, virulence in vivo, and
comparative genomics of Leishmania isolates could be used to
investigate the prevalence of drug resistance and question further
the emergence of new pathogenic strains.
We recommend that any funding available ﬁrst be used to
standardize surveillance and reporting procedures, sampling
techniques, and diagnostic training. This is likely to have a greater
and more immediate public health impact on the CL burden.
Ideally, a temporary speciﬁc task force compiled of experts, leading
research institutions, and national Leishmania coordinators could
be formed to address these issues and lead to a new control
programme.
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